1. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994;330:613-622.
2. Lipton SA & Nakanishi N. Shakespeare in love - with NMDA receptors? Nature medicine 1999;5:270-271.
3. Ruppel RA, Kobanek PM, Adelson PD, et al. Excitatory amino acid concentrations in ventricular cerebrospinal fluid after severe traumatic brain injury in infants and children: The role of child abuse. J pediatr 2001;138:18-25.
4. Bullock R, Butcher SP, Chen MH, et al. Correlation of the extracellular glutamate concentration with extent of blood flow reduction after subdural hematoma in the rat. J Neurosurg 1991;74:794-802.
5. Geddes JF, Hackshaw AK, Vowles GH, et al. Neuropathology of inflicted head injury in children. Patterns of brain damage. Brain 2001;124:1290-1298.
6. Suh DY, Davis PC, Hopkins KL et al. Nonaccidental pediatric head injury: diffusion-weighted imaging findings. Neurosurgery 2001;49:309-320.
7. Holshouser BA, Ashwal S, Luh G, et al. Proton MR spectroscopy after central nervous system injury: outcome prediction in neonates, infants, and children. Radiology 1997;202:487-496.
8. Duhaime AC, Gennarelli LM, Boardman C. Neuroprotection by dextromethorphan in acute experimental subdural hematoma in the rat. J Neurotrauma 1996;13:79-84.
9. Ikonomidou C, Qin Y, Labruyere J, Kirby C, et al. Prevention of trauma-induced neurodegeneration in infant rat brain. Pediatr Reseach 1996;39:1020-1027.
10. Smith SL, Hall ED. Tirilazad widens the therapeutic window for riluzole-induced attenuation of progressive cortical degeneration in an infant rat model of the shaken baby syndrome. J Neurotrauma 1998;15:707-719.
11. Johnston MV. Neonatal Hypoxic-ischemic brain insults and their mechanisms. In: New concepts incerebral ischemia. New York, NY: CRC Press, 2002;33-51.
12. Wolf RL, Zimmerman RA, Clancy R, et al. Quantitative apparent diffusion coefficient measurements in term neonates for early detection of hypoxic-ischemic brain injury: Initial experience. Radiology 2001;218:825-833.
13. Barkovich AJ, Westmark KD, Bedi HS, et al. Proton spectroscopy and diffusion imaging on first day of life after perinatal asphyxia: preliminary report. AJNR 2001;22:1786-1794.
14. Pu Y,Li QF, Zeng CM, et al. Increased detectability of alpha brain glutamate/glutamine in neonatal hypoxic-ischemic encephalopathy. AJNR 2000;21:203-212.
15. Faden AI, Demediuk P, Panter SS, et al. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989;244:798-800.
16. Gennarelli TA. Mechanisms of brain injury. J Emergency Med 1993;11 Suppl:5-11.
17. Liu AY, Maldjian JA, Bagley LJ, Sinson GP, et al. Traumatic brain injury: diffusion-weighted MR imaging findings. AJNR 1999;20:1636-1641.
18. Brown GK, Squier MV. Neuropathology and pathogenesis of mitochondrial disease. J Inher Metab 1996;19:553-572.
19. Wilichowski E, Puowels PJW, Frahm J, et al. Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbance in patients with MELAS. Neuropediatrics 1999;30:256-263.
20. Mark LP, Prost RW, Ulmer JL, et al. Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. AJNR 2001;22:1813-1824.
21. Launes J, Siren J,Viinikka L, et al. Does glutamate mediate brain damage in acute encephalitis? Neuroreport 1998;9:577-581.
22. Fountain NB. Status epilepticus: risk factors and complications. Epilepsia 2000;41:S23-53.
23. Rollins NK, Wen TS, Dominguez R. Crossed cerebellar atrophy in children: a neurologic sequela of extreme prematurity. Pediatr radiol 1995;25:S20-25.
24. McNamara JO, Whitney KD, Andrews PI, et al. Evidence for glutamate receptor autoimmunity in the pathogenesis of Rasmussen encephalitis. Advances in Neurology 1999;19:543-550.
25. Geller E, Faerber EN, Leido A et al. Rasmussen encephalitis: complementary role of multitechnique neuroimaging. AJNR 1998;19:445-449.
26. Matute C, Alberdi E, Domercq M, et al. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci 2001;24:224-230.
27. Stover JF, Pleines UE, Morganti-Kossman MC, et al. Neurotransmitters in cerebrospinal fluid reflect pathological activity. Eur J Clin Invest 1997;27:1038-1043.
28. Werner P, Pitt D, Raine CS. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 2001;50:169-180.
29. van der Knaap MS, Leegwater PA, Konst AA, et al. Mutation in each of the five subunits of translation initiation factor eIF2B can casue leukoencephalopathy with vanishing white matter. Ann Neurol2002;51:264-270.
30. van der Knaap MS, Wevers RA, Kure S, et al. Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencephalopathy with vanishing white matter. J Child Neurol 1999;14:728-731.
31. van der Knaap MS, Barth PG, Gabreels FJ, et al. A new leukoencephalopathy with vanishing white matter. Neurology 1997;48:845-855.
32. Epstein LG, Gelbard HA. HIV-1-induced neuronal injury in the developing brain. Journal of Leukocyte biology 1999;65:453-457.
33. Kaufman WM, Sivit CJ, Fitz CR, et al. CT and MR evaluation of intracranial involvement in pediatric HIV infection: a clinical imaging correlation. AJNR 1992;13:949-957.
34. Hamberger A, Gillberg C, Palm A, et al. Elevated CSF glutamate in Rett syndrome. Neuropediatrics 1992;23:212-213.
35. Murakami JW, Courchesne E, Haas RH, et al. Cerebellar and cerebral abnormalities in Rett sydrome: aquantative MR analysis. AJNR 1992;159:177-183.
36. Naidu S, Kaufman WE, Abrams MT, et al. Neuroimaging studies in Rett syndrome. Brain Dev 2001;23:S62-71.

Acknowledgement: We are grateful to Theresa Kubera for her assistance in the preparation of this exhibit